Trial Information
Bangladesh Vitamin E and Selenium Trial
Inclusion Criteria:
- Manifest arsenic skin lesions (melanosis, leucomelanosis, or keratosis)
- Aged 25 to 65 years
- Permanent resident of study area
Exclusion Criteria:
- Pregnancy
- Clinically too ill (enlarged spleen or liver)
- Presence of gangrene
- Cancer
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Outcome Measure:
Skin Cancer
Outcome Time Frame:
Incidence during the 6-year study period
Safety Issue:
No
Principal Investigator
Habibul Ahsan, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Chicago
Authority:
Bangladesh: Ethical Review Committee
Study ID:
15091A (R01-CA10743-1)
NCT ID:
NCT00392561
Start Date:
April 2006
Completion Date:
June 2016
Related Keywords:
- Non-melanoma Skin Cancer
- Skin Neoplasms
- Carcinoma, Basal Cell
- Carcinoma, Basosquamous
- Carcinoma, Squamous Cell